Vanguard Group Inc Tarsus Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,226,595 shares of TARS stock, worth $100 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,226,595

Previous 2,115,162 5.27%

Holding current value

$100 Million

Previous $117 Million 2.34%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$41.29 - $56.94 $4.6 Million - $6.34 Million	111,433 Added 5.27%	2,226,595 $114 Million
Q4 2024 Feb 11, 2025	BUY	$32.27 - $55.37 $575,664 - $987,745	17,839 Added 0.85%	2,115,162 $117 Million
Q3 2024 Nov 13, 2024	BUY	$21.54 - $34.6 $2.32 Million - $3.72 Million	107,630 Added 5.41%	2,097,323 $69 Million
Q2 2024 Aug 13, 2024	BUY	$25.17 - $38.73 $4.1 Million - $6.32 Million	163,061 Added 8.93%	1,989,693 $54.1 Million
Q1 2024 May 10, 2024	BUY	$19.61 - $39.22 $4.53 Million - $9.06 Million	231,131 Added 14.49%	1,826,632 $66.4 Million
Q4 2023 Feb 14, 2024	BUY	$12.98 - $20.73 $567,213 - $905,880	43,699 Added 2.82%	1,595,501 $32.3 Million
Q3 2023 Nov 14, 2023	BUY	$14.75 - $24.62 $4.66 Million - $7.78 Million	316,128 Added 25.58%	1,551,802 $27.6 Million
Q2 2023 Aug 14, 2023	BUY	$11.57 - $19.63 $117,238 - $198,910	10,133 Added 0.83%	1,235,674 $22.3 Million
Q1 2023 May 15, 2023	BUY	$11.92 - $16.27 $155,806 - $212,665	13,071 Added 1.08%	1,225,541 $15.4 Million
Q4 2022 Feb 10, 2023	BUY	$14.12 - $18.72 $3.91 Million - $5.18 Million	276,821 Added 29.59%	1,212,470 $17.8 Million
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $3.94 Million - $5.18 Million	279,826 Added 42.67%	935,649 $16 Million
Q2 2022 Aug 12, 2022	BUY	$11.08 - $19.08 $2.18 Million - $3.76 Million	197,007 Added 42.94%	655,823 $9.58 Million
Q1 2022 May 13, 2022	SELL	$14.49 - $24.28 $5,419 - $9,080	-374 Reduced 0.08%	458,816 $7.72 Million
Q4 2021 Feb 14, 2022	BUY	$21.21 - $29.68 $640,542 - $896,336	30,200 Added 7.04%	459,190 $10.3 Million
Q3 2021 Nov 12, 2021	BUY	$21.45 - $29.22 $63,170 - $86,052	2,945 Added 0.69%	428,990 $9.25 Million
Q2 2021 Aug 13, 2021	BUY	$27.16 - $38.59 $11.6 Million - $16.4 Million	426,045 New	426,045 $12.3 Million

Others Institutions Holding TARS

# of Institutions

201

Shares Held

44.5M

Call Options Held

19.9K

Put Options Held

7.6K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.2B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Tarsus Pharmaceuticals, Inc. Transaction History